[Experimental study on effect of jiangya maijing liquid on spontaneous hypertension rats fed with high lipid diet].
OBJECTIVE
To observe and identify the effect of Jiangya Maijing Liquid (JYMJL) on spontaneous hypertension rats (SHR) fed with high lipid diet in antagonizing hypertension and hyperlipidemia and improving pathological changes of kidney.


METHODS
Forty-two SHR were divided into 5 groups, except Group A, the Groups B-E were fed with high lipid diet, and Group C, D and E was treated with JYMJL, western drug and Niuhuang Jiangya pill respectively. Besides, Group F was set up for control with normal rats fed by normal diet. The changes of blood pressure (BP), biological indices and renal pathology were observed in the 14 weeks' period of observation.


RESULTS
(1) BP raised significantly in Group A and B, it became stable in Group C from the 5th week on and was lower than the BP in other groups (P < 0.01). BP in Group F was not changed; (2) The highest level of nitric oxide (NO) was shown in Group F, and that in Group B and E was lower than that in Group C and D; (3) Level of cholesterol was lower in Group A and F than that in Group C, D and E (P < 0.01), and that in Group C was lower than that in Group B and E (P < 0.01 and P < 0.05 respectively); (4) Pathologic examination on kidney showed that no change was found in Group F, the most severe change was shown in Group B among Group B-E, and the improvement after treatment in Group C was better than that in group B (P < 0.01).


CONCLUSIONS
(1) Condition of disease in rats with hypertension complicated with hyperlipidemia was more severe than that with simple hypertension; (2) JYMJL could restrain the developing of hypertension in SHR, the mechanism may be related with the raising of NO; (3) JYMJL has effect of lowering blood lipid; (4) JYMJL has kidney protective effect, it could alleviate the pathological changes in kidney by way of lowering BP and blood lipid.
Huang
Li
L
China-Japan Friendship Hospital, Beijing 100029.
Shi
Zai-xiang
ZX
Zhang
Jiu-liang
JL
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D004041:Dietary Fats / Q000008:administration & dosage; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D005260:Female; D006949:Hyperlipidemias / Q000209:etiology / Q000473:pathology*; D006973:Hypertension / Q000150:complications / Q000473:pathology*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007668:Kidney / Q000473:pathology*; D008297:Male; D008517:Phytotherapy; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY
D000959:Antihypertensive Agents; D004041:Dietary Fats; D004365:Drugs, Chinese Herbal; D000960:Hypolipidemic Agents